- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 0.47 | -7.15 | 0.51 | 1.93 | 0.02 | 1.35 | N/A | - | ||
| 2026/3 | 0.5 | 33.11 | 6.72 | 1.47 | -0.13 | 1.47 | 1.41 | - | ||
| 2026/2 | 0.38 | -35.13 | -6.56 | 0.96 | -3.38 | 1.47 | 1.41 | - | ||
| 2026/1 | 0.58 | 14.98 | -1.2 | 0.58 | -1.2 | 1.57 | 1.31 | - | ||
| 2025/12 | 0.51 | 5.03 | 7.6 | 5.7 | -6.81 | 1.51 | 1.25 | - | ||
| 2025/11 | 0.48 | -6.1 | -4.83 | 5.19 | -8.01 | 1.45 | 1.3 | - | ||
| 2025/10 | 0.51 | 14.78 | 3.16 | 4.71 | -8.33 | 1.42 | 1.33 | - | ||
| 2025/9 | 0.45 | -1.11 | -1.71 | 4.19 | -9.56 | 1.34 | 1.26 | - | ||
| 2025/8 | 0.45 | 2.84 | -23.08 | 3.74 | -10.42 | 1.36 | 1.25 | - | ||
| 2025/7 | 0.44 | -4.68 | -2.99 | 3.29 | -8.34 | 1.36 | 1.25 | - | ||
| 2025/6 | 0.46 | 1.88 | -12.44 | 2.85 | -9.12 | 1.38 | 1.08 | - | ||
| 2025/5 | 0.45 | -2.46 | -8.45 | 2.39 | -8.44 | 1.39 | 1.07 | - | ||
| 2025/4 | 0.47 | -1.41 | -3.02 | 1.93 | -8.44 | 1.34 | 1.11 | - | ||
| 2025/3 | 0.47 | 16.53 | -8.1 | 1.47 | -10.04 | 1.47 | 0.95 | - | ||
| 2025/2 | 0.41 | -31.42 | 1.23 | 1.0 | -10.93 | 1.47 | 0.95 | - | ||
| 2025/1 | 0.59 | 25.24 | -17.71 | 0.59 | -17.71 | 1.57 | 0.89 | - | ||
| 2024/12 | 0.47 | -7.11 | -6.62 | 6.11 | 0.77 | 1.48 | 0.95 | - | ||
| 2024/11 | 0.51 | 1.79 | -4.31 | 5.64 | 1.44 | 1.46 | 0.96 | - | ||
| 2024/10 | 0.5 | 9.34 | -2.49 | 5.13 | 2.05 | 1.54 | 0.91 | - | ||
| 2024/9 | 0.46 | -22.6 | -6.48 | 4.64 | 2.57 | 1.5 | 0.93 | - | ||
| 2024/8 | 0.59 | 29.7 | 11.67 | 4.18 | 3.66 | 1.57 | 0.88 | - | ||
| 2024/7 | 0.45 | -13.97 | -2.17 | 3.59 | 2.46 | 1.48 | 0.94 | - | ||
| 2024/6 | 0.53 | 6.52 | -17.04 | 3.14 | 3.16 | 1.5 | 0.88 | - | ||
| 2024/5 | 0.5 | 3.32 | -0.74 | 2.61 | 8.52 | 1.49 | 0.89 | - | ||
| 2024/4 | 0.48 | -6.57 | 15.46 | 2.11 | 10.96 | 1.39 | 0.95 | - | ||
| 2024/3 | 0.51 | 28.38 | -16.3 | 1.63 | 9.7 | 1.63 | N/A | - | ||
| 2024/2 | 0.4 | -44.25 | 5.26 | 1.12 | 27.97 | 1.62 | N/A | - | ||
| 2024/1 | 0.72 | 42.12 | 45.47 | 0.72 | 45.47 | 1.75 | N/A | - | ||
| 2023/12 | 0.51 | -4.81 | -3.82 | 6.07 | 22.64 | 1.55 | N/A | - | ||
| 2023/11 | 0.53 | 3.73 | 20.19 | 5.56 | 25.79 | 1.53 | N/A | - | ||
| 2023/10 | 0.51 | 4.86 | 15.05 | 5.03 | 26.41 | 1.53 | N/A | - | ||
| 2023/9 | 0.49 | -7.57 | 13.26 | 4.52 | 27.84 | 1.48 | N/A | - | ||
| 2023/8 | 0.53 | 13.61 | 33.06 | 4.03 | 29.86 | 1.63 | N/A | - | ||
| 2023/7 | 0.46 | -27.04 | 5.96 | 3.5 | 29.39 | 1.6 | N/A | - | ||
| 2023/6 | 0.64 | 27.45 | 51.8 | 3.04 | 33.92 | 1.55 | N/A | 因受到流感、腸病毒及新冠疫情影響，相關藥品出貨量增加，及反映原物料上漲調整藥品售價，使得6月單月營收較去年同期大幅成長。 | ||
| 2023/5 | 0.5 | 20.19 | 32.2 | 2.4 | 29.87 | 1.53 | N/A | - | ||
| 2023/4 | 0.42 | -32.28 | 12.89 | 1.9 | 29.27 | 1.41 | N/A | - | ||
| 2023/3 | 0.61 | 61.47 | 69.9 | 1.49 | 34.73 | 1.49 | N/A | 112年3月單月合併營收較去年同期成長69.90%，係因自112年3月起部分產品調整售價及市場需求量增加，以致營收成長。 | ||
| 2023/2 | 0.38 | -22.97 | 9.97 | 0.87 | 17.62 | 1.4 | N/A | - | ||
| 2023/1 | 0.49 | -6.04 | 24.28 | 0.49 | 24.28 | 1.46 | N/A | - | ||
| 2022/12 | 0.53 | 18.96 | 41.52 | 4.95 | 20.21 | 1.41 | N/A | - | ||
| 2022/11 | 0.44 | -0.7 | 26.49 | 4.42 | 18.1 | 1.32 | N/A | - | ||
| 2022/10 | 0.44 | 3.23 | 28.93 | 3.98 | 17.23 | 1.27 | N/A | - | ||
| 2022/9 | 0.43 | 8.58 | 22.43 | 3.54 | 15.91 | 1.27 | N/A | - | ||
| 2022/8 | 0.4 | -9.52 | 20.14 | 3.1 | 15.06 | 1.25 | N/A | - | ||
| 2022/7 | 0.44 | 4.51 | 36.32 | 2.71 | 14.35 | 1.24 | N/A | - | ||
| 2022/6 | 0.42 | 10.99 | 31.33 | 2.27 | 10.9 | 1.17 | N/A | - | ||
| 2022/5 | 0.38 | 2.63 | 9.15 | 1.85 | 7.12 | 1.11 | N/A | - | ||
| 2022/4 | 0.37 | 1.9 | 14.0 | 1.47 | 6.62 | 1.08 | N/A | - | ||
| 2022/3 | 0.36 | 4.51 | 6.87 | 1.1 | 4.36 | 1.1 | N/A | - | ||
| 2022/2 | 0.35 | -12.94 | 8.09 | 0.74 | 3.18 | 1.11 | N/A | - | ||
| 2022/1 | 0.4 | 6.98 | -0.73 | 0.4 | -0.73 | 1.12 | N/A | - | ||
| 2021/12 | 0.37 | 6.33 | -4.46 | 4.11 | -2.95 | 1.06 | N/A | - | ||
| 2021/11 | 0.35 | 1.2 | 12.0 | 3.74 | -2.8 | 1.05 | N/A | - | ||
| 2021/10 | 0.34 | -1.96 | 3.18 | 3.39 | -4.1 | 1.03 | N/A | - | ||
| 2021/9 | 0.35 | 6.54 | 10.87 | 3.05 | -4.86 | 1.0 | N/A | - | ||
| 2021/8 | 0.33 | 2.66 | 0.88 | 2.7 | -6.59 | 0.97 | N/A | - | ||
| 2021/7 | 0.32 | 0.68 | -21.35 | 2.37 | -7.54 | 0.99 | N/A | - | ||
| 2021/6 | 0.32 | -7.74 | 1.74 | 2.05 | -4.92 | 0.0 | N/A | - | ||
| 2021/5 | 0.35 | 7.19 | 21.75 | 1.73 | -6.06 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/1 | 0.58 | 2025/1 | 0.59 | 2024/1 | 0.72 | 2023/1 | 0.49 | 2022/1 | 0.4 |
| 2026/2 | 0.38 | 2025/2 | 0.41 | 2024/2 | 0.4 | 2023/2 | 0.38 | 2022/2 | 0.35 |
| 2026/3 | 0.5 | 2025/3 | 0.47 | 2024/3 | 0.51 | 2023/3 | 0.61 | 2022/3 | 0.36 |
| 2026/4 | 0.47 | 2025/4 | 0.47 | 2024/4 | 0.48 | 2023/4 | 0.42 | 2022/4 | 0.37 |
| N/A | N/A | 2025/5 | 0.45 | 2024/5 | 0.5 | 2023/5 | 0.5 | 2022/5 | 0.38 |
| N/A | N/A | 2025/6 | 0.46 | 2024/6 | 0.53 | 2023/6 | 0.64 | 2022/6 | 0.42 |
| N/A | N/A | 2025/7 | 0.44 | 2024/7 | 0.45 | 2023/7 | 0.46 | 2022/7 | 0.44 |
| N/A | N/A | 2025/8 | 0.45 | 2024/8 | 0.59 | 2023/8 | 0.53 | 2022/8 | 0.4 |
| N/A | N/A | 2025/9 | 0.45 | 2024/9 | 0.46 | 2023/9 | 0.49 | 2022/9 | 0.43 |
| N/A | N/A | 2025/10 | 0.51 | 2024/10 | 0.5 | 2023/10 | 0.51 | 2022/10 | 0.44 |
| N/A | N/A | 2025/11 | 0.48 | 2024/11 | 0.51 | 2023/11 | 0.53 | 2022/11 | 0.44 |
| N/A | N/A | 2025/12 | 0.51 | 2024/12 | 0.47 | 2023/12 | 0.51 | 2022/12 | 0.53 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 26Q1 (8) | 0.14 | 133.33 | 100.0 |
| 25Q4 (7) | 0.06 | 20.0 | -25.0 |
| 25Q3 (6) | 0.05 | -44.44 | -44.44 |
| 25Q2 (5) | 0.09 | 28.57 | 0.0 |
| 25Q1 (4) | 0.07 | -12.5 | 0.0 |
| 24Q4 (3) | 0.08 | -11.11 | 0.0 |
| 24Q3 (2) | 0.09 | 0.0 | 0.0 |
| 24Q2 (1) | 0.09 | 0.0 | 0.0 |